Prince Harry won't travel to the UK for the first day of his trial against the tabloid media. The trial is against News Group ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.

Harry Goularte mugshot The man accused of molesting the son of former UFC heavyweight champion Cain Velasquez has a jury trial date set in a near-three-year-long criminal case.

The terms “capitalist economy” and “free market economy” are often used interchangeably, but there are differences, at least in the theories that underpin them. In both, the law of supply ...

Starbucks Korea is brewing up excitement in 2025 with a magical collaboration featuring beloved Harry Potter-inspired products. In partnership with Warner Bros. Discovery Global Consumer Products, ...

Shaving with a straight razor is the best way to get a close shave, but the easiest way to filet your face. Here’s how to avoid becoming steak. It is not surprising that the expression “a ...

WITNESS COMES BACK FOR THE SECOND TRIAL. THE TRUTH, THE WHOLE TRUTH AND NOTHING BUT THE TRUTH. SO HELP YOU GOD. I DO. THANK YOU. ONE OF ONLY A HANDFUL OF WITNESSES. THE DEFENSE CALLED DURING KAREN ...

DEDHAM – Special prosecutor Hank Brennan, who was brought in for Karen Read's upcoming second trial, is asking the court to exclude testimony about witness Jen McCabe's "ho[w] long to die in ...

Kevin Mazur/Getty Meghan Markle is stepping in front of the camera for her upcoming Netflix series, with her husband, Prince Harry, supporting her in this latest venture. On Jan. 2, the Duchess of ...

Brain teasers come in various forms—some test your maths skills, while others are age-related riddles. Despite their diversity, one thing remains constant: they always capture the attention of ...

Get ready to have the smoothest shave of your life by snagging some ethically responsible options from Nimbi, the world’s first plastic-free razor brand for women. Nimbi Disposable Razors are ...

A new depression treatment developed by startup Neumora Therapeutics failed in a Phase 3 clinical trial — the company’s first late-stage readout. The drug, navacaprant, failed to show a ...